Nexion Biosensor Platform®
Intellectual Property
Bio Nexa’s technologies are supported by a strategically developed intellectual property portfolio, including a provisional patent filed with the United States Patent and Trademark Office (USPTO), establishing a defensible foundation for commercialization, U.S. based manufacturing, and secure deployment in healthcare and bio-defense environments.